Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Vizz (aceclidine ophthalmic solution) for the Treatment of Presbyopia
LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), today announced the US Food and Drug Administration (“FDA”)...
FDA Approves Vostally (ramipril) Oral Solution for the Treatment of Hypertension in Adults
Greenville, SC – July 31, 2025 – Rosemont Pharmaceuticals, Inc. announced that on July 23, 2025, the U.S. Food and Drug Administration (FDA)...
FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors
Novo Nordisk announced today that the US Food and Drug Administration (FDA) approved Alhemo (concizumab-mtci) injection as a once-daily prophylaxis...
Novartis' Twice-Yearly Leqvio (inclisiran) Receives FDA Approval for New Indication Enabling First-Line Use
Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio (inclisiran), enabling its use as monotherapy...
FDA Approves Sephience (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has approved Sephience™...
Scientists Find New Ecosystem in Deepest Trenches of Pacific Ocean
SUNDAY, August 3, 2025 — A scientific expedition into a region of the Pacific Ocean named for Hades, Greek god of the underworld, has uncovered an...
Do Millipedes Hold Key to Pain Relief, Parkinson's Treatment?
SATURDAY, August 2, 2025 — To fend off predators, millipedes release defensive compounds that could one day play a part in treating pain and neurological...
FDA Approves Empaveli for Rare Kidney Diseases
The U.S. Food and Drug Administration has approved Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex...
Cannabis Use Disorder Linked to Increased Risk for Oral Cancer
Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine...
Increases in Local Violence Tied to Higher Subsequent Suicide Rates
At the county level, increases in homicide rates are linked to higher suicide rates the following year, according to a study published online July...
Preemies' Early-Life Medical Risk Tied to Worse Health at Age 35
Higher early-life medical risk among preterm infants is associated with increased occurrence of mental health disorders, cardiometabolic issues, and body...
New Health Record System Aims to Make Sharing Info Easier, Trump Says
FRIDAY, Aug. 1, 2025 — President Donald Trump has introduced a new effort to help Americans more easily share their health records with doctors,...
Hulk Hogan’s Cause of Death Revealed: Heart Attack at Age 71
FRIDAY, Aug. 1, 2025 — Pro wrestling icon Hulk Hogan died of a heart attack, Florida officials confirmed Thursday. The 71-year-old entertainer,...
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated...
Sanofi’s SAR446523, a GPRC5D Monoclonal Antibody, Earns Orphan Drug Designation in the US for Multiple Myeloma
Paris, July 30, 2025. The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, an IgG1-based Antibody-Dependent...
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for...
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action...
Is It Chronic Fatigue? Listen to Your Gut, Research Suggests
TUESDAY, July 29, 2026 — Artificial intelligence (AI) may be guiding doctors towards a gut-focused means of accurately diagnosing chronic fatigue...
Recently Added
Recently added consumer and prescribing information: Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Vizz Vizz (aceclidine) is a cholinergic agonist indicated for the treatment of presbyopia in adults.
- Vostally Vostally (ramipril) is an oral solution formulation of the approved angiotensin converting enzyme (ACE) inhibitor ramipril used for the...
- Sephience Sephience (sepiapterin) is a phenylalanine hydroxylase activator used for the treatment of patients with phenylketonuria.